4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT01413139

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01413139
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01413139. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2011-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease
Acronym
4-EVER
Condition
Peripheral Vascular Disease
Condition
Claudication
Intervention (Device)
4F portfolio products from Biotronik
Lead sponsor
Flanders Medical Research Program (class: research network)

Record details

Record id
cardio:ct-nct01413139
Content hash
dcad5d76ff34e348c82eaecd39666841ee64b663057b2f61112860d9e6aea16d